|
Trade Name | LIPOSORBER LA-15 SYSTEM |
Classification Name | apheresis for focal glomerulosclerosis in adult and pediatric patients |
Generic Name | apheresis for focal glomerulosclerosis in adult and pediatric patients |
Applicant |
KANEKA PHARMA AMERICA LLC |
546 fifth ave., 21st floor |
new york, NY 10036 |
|
HDE Number | H120005 |
Supplement Number | S004 |
Date Received | 03/21/2016 |
Decision Date | 03/23/2016 |
Product Code | |
Advisory Committee |
Gastroenterology |
Supplement Type | 30-day notice |
Supplement Reason | process change - manufacturer/sterilizer/packager/supplier |
Expedited Review Granted? | No |
Combination Product | No |
Approval Order Statement Implementation of a new manufacturing site for the vendor [neat co. , ltd. ] of the gd cap component of the sulflux® kp-05 as part of the liposorber® la-15 system. |